Blueprint Medicines Corporation
NASDAQ: BPMC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kathryn Haviland
- Employees
- 682
- Headquarters
- Cambridge, United States
- IPO year
- 2015
- Market cap
- $8.4B
- Website
- https://www.blueprintmedicines.com
Loading BPMC…
Loading profile data…Frequently asked questions about BPMC
What does Blueprint Medicines Corporation (BPMC) do?
Blueprint Medicines Corporation is a biopharmaceutical company dedicated to pioneering precision therapies. Its core mission involves developing innovative treatments for various cancers and specific blood disorders, specifically those identified by genomic markers. These efforts extend to patients both within the United States and across intern...
Where does BPMC trade?
Blueprint Medicines Corporation (BPMC) trades on the NASDAQ Global Select.
What sector is BPMC in?
Blueprint Medicines Corporation (BPMC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Blueprint Medicines Corporation?
Kathryn Haviland is the chief executive officer of Blueprint Medicines Corporation (BPMC).
Where is Blueprint Medicines Corporation headquartered?
Blueprint Medicines Corporation is headquartered in United States.
Does BPMC pay a dividend?
Blueprint Medicines Corporation (BPMC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BPMC go public?
Blueprint Medicines Corporation (BPMC) completed its initial public offering in 2015.